Exploring resistance patterns in urinary tract infections among pregnant women: a Saudi Arabian perspective
Abstract
Urinary tract infections (UTIs) can lead to poor maternal and perinatal outcomes. We designed this study to assess the susceptibility patterns of urinary pathogens to antimicrobials, along with their safety for the mother and fetus, to ensure effective UTI treatment during pregnancy. This retrospective study was conducted to assess bacterial UTIs in the inpatient department of a tertiary care teaching hospital in Saudi Arabia. A total of 154 pregnant women with a confirmed case of UTI were included. Urine samples were collected by both urinary catheterization and the midstream urine (MSU) method per the standard procedure. We observed that around 52% of participants were in the 26-35 age group. The most common isolate was Escherichia coli (58.44%), followed by Klebsiella pneumoniae (22.73%) and Streptococcus group B (3.90%). Considering Escherichia coli isolates, nitrofurantoin (49.35%) showed the highest efficacy among participants, followed by piperacillin–tazobactam (40%), trimethoprim–sulfamethoxazole (TMP-SMZ-40%), and gentamicin (61%). In prenatal care, it is of the utmost importance to regularly evaluate the susceptibility and resistance pattern of antimicrobials to UTI-related pathogens during the course of pregnancy to provide optimal therapy for both mothers and infants.